https://orcid.org/0000-0003-2376-1606
Citations (4)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Rei Fujiki, Tomotaka Kawayama, Kyoji Furukawa, Takashi Kinoshita, Kazuko Matsunaga & Tomoaki Hoshino. (2023) The Efficacy and Safety of First-Line Single-Inhaler Triple versus Dual Therapy in Controller-Naïve and Symptomatic Adults with Asthma: A Preliminary Retrospective Cohort Study. Journal of Asthma and Allergy 16, pages 227-237.
Read now
Read now
Fulvio Braido, Angelica Tiotiu, Guillermo Guidos-Fogelbach, Ilaria Baiardini, Filippo Cosini, Jaime Correia de Sousa, Andras Bikov, Sylvia Novakova, Marina Labor, Igor Kaidashev, Denislava Nedeva, Krzysztof Kowal, Stefan Mihaicuta, Marilyn Urrutia Pereira, Dirceu Solé, Plamela Novakova, Herberto Chong-Neto, Laura Vrzy, Ignacio J. Ansotegui, Jonathan A. Bernstein, Louis-Philippe Boulet, Giorgio Walter Canonica, Lawrence Dubuske, Carlos Nunes, Juan Carlos Ivancevich, Pierachille Santus, Nelson Rosario, Alexander Emelyanov & Paschalis Steiropoulos. (2022) Manifesto on inhaled triple therapy in asthma: an Interasma (Global Asthma Association – GAA) document. Journal of Asthma 59:12, pages 2402-2412.
Read now
Read now
Soichiro Hozawa, Hiroyuki Ohbayashi, Michiko Tsuchiya, Yu Hara, Laurie A Lee, Takashi Nakayama, Jun Tamaoki, Andrew Fowler & Takanobu Nishi. (2021) Safety of Once-Daily Single-Inhaler Triple Therapy with Fluticasone Furoate/Umeclidinium/Vilanterol in Japanese Patients with Asthma: A Long-Term (52-Week) Phase III Open-Label Study. Journal of Asthma and Allergy 14, pages 809-819.
Read now
Read now
Articles from other publishers (1)
Dinesh Yogaratnam, Katherine M. Carey, Valerie Coppenrath, Aimee Dawson, Branson Facemire, Claire Jackson, Amy B.W. LaMothe & Ann M. Lynch. 2022. A Worldwide Yearly Survey of New Data in Adverse Drug Reactions. A Worldwide Yearly Survey of New Data in Adverse Drug Reactions
409
419
.